CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 915913-916181 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T17071","span":{"begin":0,"end":268},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We have identified several candidate markers for MS and to confirm their specific immunoreactivity, phage ELISA will be performed on CSF and serum of individual patients used in the SAS procedure, additional MS patients and controls with other (neurological) diseases."}

{"project":"Epistemic_Statements","denotations":[{"id":"T2007","span":{"begin":0,"end":268},"obj":"Epistemic_statement"}],"text":"We have identified several candidate markers for MS and to confirm their specific immunoreactivity, phage ELISA will be performed on CSF and serum of individual patients used in the SAS procedure, additional MS patients and controls with other (neurological) diseases."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T198","span":{"begin":0,"end":268},"obj":"Sentence"}],"text":"We have identified several candidate markers for MS and to confirm their specific immunoreactivity, phage ELISA will be performed on CSF and serum of individual patients used in the SAS procedure, additional MS patients and controls with other (neurological) diseases."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3817","span":{"begin":49,"end":51},"obj":"Body_part"},{"id":"T3818","span":{"begin":133,"end":136},"obj":"Body_part"},{"id":"T3819","span":{"begin":141,"end":146},"obj":"Body_part"},{"id":"T3820","span":{"begin":208,"end":210},"obj":"Body_part"}],"attributes":[{"id":"A3817","pred":"uberon_id","subj":"T3817","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A3818","pred":"uberon_id","subj":"T3818","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"id":"A3819","pred":"uberon_id","subj":"T3819","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A3820","pred":"uberon_id","subj":"T3820","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"We have identified several candidate markers for MS and to confirm their specific immunoreactivity, phage ELISA will be performed on CSF and serum of individual patients used in the SAS procedure, additional MS patients and controls with other (neurological) diseases."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5733","span":{"begin":49,"end":51},"obj":"Disease"},{"id":"T5734","span":{"begin":208,"end":210},"obj":"Disease"},{"id":"T40199","span":{"begin":49,"end":51},"obj":"Disease"},{"id":"T74675","span":{"begin":208,"end":210},"obj":"Disease"},{"id":"T5697","span":{"begin":244,"end":267},"obj":"Disease"}],"attributes":[{"id":"A5733","pred":"mondo_id","subj":"T5733","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A5734","pred":"mondo_id","subj":"T5734","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A38360","pred":"mondo_id","subj":"T40199","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A27543","pred":"mondo_id","subj":"T74675","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A55519","pred":"mondo_id","subj":"T5697","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"}],"text":"We have identified several candidate markers for MS and to confirm their specific immunoreactivity, phage ELISA will be performed on CSF and serum of individual patients used in the SAS procedure, additional MS patients and controls with other (neurological) diseases."}